Thrombosis risk stratification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(14 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
{{Thrombosis}}
{{Thrombosis}}
{{CMG}} {{AE}} {{VE}}


{{CMG}}
==Overview==
'''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]
Presence of a [[thrombophilia|risk factor for thrombosis]] has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor.
==Risk stratification==
It is defined as the ability to predict outcomes from a given intervention by arranging patients according to the severity of their illness.


{|style="background:LightSkyBlue" border="1"
==Risk Factors==
|-
The Thrombosis formation is a phenomenon that can be elicited by various conditions, all of which take effect by means of mechanisms of [[Virchow's triad]]. Blood stasis, endothelial defect or [[hypercoagulability]].   
|Age
|(continuous)
|-
|Body mass index
|(continuous)
|-
|Smoking status
|(non-smoker; ex-smoker; light, moderate, or heavy smoker)
|-
|Townsend deprivation score
|(continuous)
|-
|Varicose veins
|(yes/no)
|-
|Congestive cardiac failure
|(yes/no)
|-
|Rheumatoid arthritis
|(yes/no)
|-
|Chronic renal disease
|(yes/no)
|-
|Inflammatory bowel disease
|(yes/no)
|-
|Cancer
|(lung, gastrointestinal, pancreas, renal, breast, prostate, other)
|-
|Recent hospital admission
|yes/no)
|-
|Recent hip fracture or hip surgery (or both)
|yes/no)
|-
|Current use of antipsychotic drugs
|(none, atypical, typical)
|-
|Current use of tamoxifen
|(yes/no)
|-
|Current use of hormone replacement therapy
|(none, equine or non-equine hormone replacement therapy)
|-
|Use of antiplatelets
|(yes/no)
|-
|Cardiovascular disease
|(stroke, transient ischaemic attack, or coronary heart disease)
|-
|Atrial fibrillation
|(yes/no)
|-
|Asthma
|(yes/no)
|-
|Chronic obstructive pulmonary disease
|(yes/no)
|-
|Family history of venous thromboembolism
|(yes/no)
|}


==Source==
*General
[http://www.bmj.com/content/343/bmj.d4656.full]
**Older age
**Female gender
**[[Smoking]]
**[[Obesity]]
**[[Pregnancy]]
**Immobilization


{{Circulatory system pathology}}
*Medical
{{SIB}}
**Surgery
**[[Congestive heart failure and thrombosis|Heart failure]]
**[[Trauma]]
**[[Oral contraceptive]] use
**[[Varicose vein]]s
**[[Malignancy]]
**Kidney disorders
**[[Lupus anticoagulant]]
**[[Paroxysmal nocturnal hemoglobinuria]]
**[[Inflammatory bowel disease]]
**[[Thromboangiitis obliterans]]
**[[Disseminated intravascular coagulation]]
 
*Familial
**[[Antithrombin|Antithrombin III deficiency]]
**[[Protein C deficiency]]/[[Protein S deficiency]]
**APC resistance ([[Factor V Leiden]])
**Dysfibrogenemia
**Hypoplasminogenemia
**Familial homocysteinemia
 
==References==
{{reflist|2}}


[[Category:Hematology]]
[[Category:Hematology]]
Line 83: Line 46:
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[cs:Trombóza]]
[[de:Thrombose]]
[[eo:Trombozo]]
[[it:Trombosi]]
[[he:תרומבוס]]
[[ms:Trombotik]]
[[nl:Trombose]]
[[pt:Trombose]]
[[fi:Verihiutale]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 09:05, 29 January 2019

Thrombosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Classification

Arterial
Venous
Arterial and Venous Thrombosis: Differences and Similarities

Causes

Site of Thrombosis

Arterial
Venous

Differentiating Thrombosis from other Diseases

Arterial
Venous

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Evaluation

Treatment

Risk Factor Modifications

Prevention

Thrombosis risk stratification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombosis risk stratification

CDC onThrombosis risk stratification

Thrombosis risk stratification in the news

Blogs on Thrombosis risk stratification

to Hospitals Treating Thrombosis risk stratification

Risk calculators and risk factors for Thrombosis risk stratification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Vahid Eidkhani, M.D.

Overview

Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor.

Risk Factors

The Thrombosis formation is a phenomenon that can be elicited by various conditions, all of which take effect by means of mechanisms of Virchow's triad. Blood stasis, endothelial defect or hypercoagulability.

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Thrombosis_risk_stratification&oldid=1542699"